|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1994-9-20
|
|
pubmed:abstractText |
Fludarabine (FLU) is a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Recently, some in vitro reports have showed the effective role of FLU on the activation of apoptosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
127-31
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8063259-Antineoplastic Agents,
pubmed-meshheading:8063259-Apoptosis,
pubmed-meshheading:8063259-Cell Separation,
pubmed-meshheading:8063259-Humans,
pubmed-meshheading:8063259-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:8063259-Tumor Cells, Cultured,
pubmed-meshheading:8063259-Vidarabine
|
|
pubmed:articleTitle |
Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.
|
|
pubmed:affiliation |
Istituto di Ematologia L. e A. Seràgnoli, Università degli Studi di Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
